Who
In numbers
- Trades disclosed
- 26
- Buys
- 14
- Sells
- 0
- Bought
- $918K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 20 Dec 2021
- Last trade
- 22 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 20 Jun 2025filed 23 Jun 2025 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 23 Dec 2024filed 26 Dec 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $88K40,000 at $2.19 | filing |
| 20 Dec 2024filed 26 Dec 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $17K7,700 at $2.17 | filing |
| 22 Aug 2024filed 26 Aug 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $18K8,100 at $2.25 | filing |
| 21 Aug 2024filed 26 Aug 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $33K15,000 at $2.23 | filing |
| 24 Jul 2024filed 31 Jul 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $13K6,000 at $2.15 | filing |
| 18 Jul 2024filed 31 Jul 2024 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $6,6243,200 at $2.07 | filing |
| 11 Jun 2024filed 21 Jun 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,587 at $0.00 | filing |
| 15 May 2024filed 20 May 2024 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,512 at $0.00 | filing |
| 11 Dec 2023filed 12 Dec 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $145K31,000 at $4.67 | filing |
| 8 Dec 2023filed 12 Dec 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $122K25,000 at $4.88 | filing |
| 15 Sep 2023filed 18 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $17K7,000 at $2.49 | filing |
| 14 Sep 2023filed 18 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $26K10,000 at $2.58 | filing |
| 12 Sep 2023filed 18 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $85K30,000 at $2.83 | filing |
| 11 Sep 2023filed 18 Sep 2023 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Bought | $72K25,000 at $2.89 | filing |
News
No headline names them, or the companies they trade most, lately.